BioBridgeXAll companies

Ceribell, Inc.

Medical device company · Sunnyvale, California, United States · Nasdaq: CBLL

Ceribell, Inc. is a medical device company headquartered in Sunnyvale, California, United States. Its shares trade on Nasdaq under the ticker CBLL. The US FDA lists 1 medical device site registered to the company, with devices in neurology. It has reported private securities offerings to the US SEC, most recently $103 million sold in a notice filed in 2022.

Profile compiled from public records. Is this your company? Request a correction or update

Ceribell at a glance

Typemedical device company
HeadquartersSunnyvale, California, United States
Stock listingNasdaq: CBLL
SEC industryElectromedical & Electrotherapeutic Apparatus
FDA-registered sites1
SEC CIK1861107

What does Ceribell do?

Medical specialties of its FDA-listed devices

Neurology

Device types listed with the FDA

Electrode, cutaneousFull-montage standard electroencephalographAutomatic event detection software for full-montage electroencephalographReduced- montage standard electroencephalographNeuropsychiatric interpretative electroencephalograph assessment aid

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $102.5 million sold (2022).

Where is Ceribell located?

Headquarters: Sunnyvale, California, United States

  • Sunnyvale, CaliforniaCeribell, Inc. · FDA device site

Frequently asked questions about Ceribell

Where is Ceribell headquartered?

Ceribell, Inc. is headquartered in Sunnyvale, California, United States.

What does Ceribell do?

Ceribell, Inc. is a medical device company. Its FDA-listed medical devices fall under neurology. Its SEC industry classification is Electromedical & Electrotherapeutic Apparatus.

Is Ceribell a public company?

Yes. Ceribell, Inc. trades on Nasdaq under the ticker CBLL.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-24. Data licences